Ethan Basch, MD, MSc
Director of the Cancer Outcomes Research Program
Bio: Ethan Basch, MD, MSc is Director of Cancer Outcomes Research at University of North Carolina at Chapel Hill. Dr. Basch is a medical oncologist and health services researcher. His clinical expertise is prostate cancer, and his research expertise includes patient-reported outcomes, drug regulatory policy, and comparative effectiveness research. He is a federally appointed member of the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI), a member of the Board of Directors of the International Society for Quality of Life Research (ISOQOL), Co-Chair of the Health Outcomes Committee of the Alliance for Clinical Trials in Oncology, and a member of the Board of Scientific Advisors of the National Cancer Institute. He leads an ongoing NCI initiative to develop a patient-reported adverse event monitoring system for use in clinical research (the \"PRO-CTCAE\"), and is study chair for multiple trials employing patient-reported endpoints. Dr. Basch holds a BA in Literature from Brown University, a Master of Philosophy (MPhil) in Literature from Oxford University, a Master of Science in Clinical Research (MSc) from Harvard School of Public Health and an MD from Harvard Medical School
Ian Buchanan, MD, MPH
Associate Vice President, Oncology Service Line
UNC Health Care System
Bio: Dr. Buchanan oversees outpatient cancer services in the newly-opened North Carolina Cancer Hospital. An expert in healthcare quality improvement and administration, Dr. Buchanan previously led UNC's Core Measures reporting efforts to CMS before accepting a position with UnitedHealth Group where he managed development and implementation of disease management and wellness programs for some of America's largest employers. Buchanan returned to UNC in late 2008 to assume his current role.
Lisa A. Carey, MD
Medical Director of the UNC Breast Center, Associate Director for Clinical Science
Bio: Lisa A. Carey, MD is the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, Medical Director of the UNC Breast Center, Chief of Hematology/Oncology, and the Physician-in-Chief of the N.C. Cancer Hospital. She graduated from Wellesley College in 1984 with a bachelor's degree in Biology and Art History. She received her medical degree from the Johns Hopkins University School of Medicine in 1990. She remained at Johns Hopkins for her residency in Internal Medicine followed by a fellowship in Medical Oncology and an advanced degree in Clinical Investigations. Dr. Carey joined the UNC faculty and Lineberger Comprehensive Cancer Center in 1998. Dr. Carey has a longstanding research interest in the clinical application of laboratory findings in breast cancer, with a particular interest in the clinical implications of different molecular subtypes of breast cancer. She designs and leads clinical trials of novel drugs and approaches, and is a close collaborator with several laboratory investigators and epidemiologists. Dr. Carey has served on the American Society of Clinical Oncology (ASCO) Scientific Program and Education Committees and as faculty for ASCO and AACR-CTRC San Antonio annual meetings for many years. She was awarded a Doris Duke Clinician Scientist Award in 1999, a Career Development Award from the National Cancer Institute (NCI) in 2000, and was inducted into the Johns Hopkins Society of Scholars in 2008. In 2011 Dr. Carey was awarded the National Cancer Institute Director's Service Award.
Lawrence Marks, MD
Chairman of the Department of Radiation Oncology
Bio: Lawrence Marks, MD is the Dr. Sidney K. Simon Distinguished Professor of Oncology Research and Chair of the University of North Carolina Department of Radiation Oncology. Dr. Marks is a recognized expert in the treatment of patients with breast and lung cancer. The thrust of his work has been aimed at improving the therapeutic ratio of radiation therapy, largely through reducing the normal tissue effects of radiation. He has conducted many prospective clinical trials to better understand radiation-induced lung and heart injury for patients receiving radiation to the chest and studies to better understanding the physiologic and dose-related causes of radiation-induced cardiopulmonary injury. He is a national leader in studying the frequency and causes of "human-errors" in the radiation oncology clinic. This work has led to the implementation of guidelines successfully reducing such errors, and hence enhances patient safety. He has published and lectured about this sensitive issue, and serves on several national panels addressing this issue. He is a member of the American Society of Radiation Oncology, the American Society of Clinical Oncology and the recipient of numerous awards and honors. Prior to joining UNC as chair in 2008, Dr. Marks was the Banks Anderson, Sr., M.D., professor of radiation oncology at Duke University, where he also directed the residency training program. He earned his MD at the University of Rochester and completed his residency in radiation medicine at the Massachusetts General Hospital.
Meghan McCann, MSN, RN, NE-BC
Director of Oncology, North Carolina Cancer Hospital
Bio: Ms. McCann is responsible for the operations of the inpatient and outpatient clinical areas and programs at the Cancer Hospital, where she has been a member of the leadership team since 2009 and has called herself a proud Tar Heel since relocating to UNC in 2002. She holds a Master\'s degree in Nursing Health Care Systems from the University of North Carolina with a Nursing Administration and Education focus, and received her Bachelor\'s in Nursing from the University of Maryland and Bachelor of Arts in Biology from the College of Notre Dame of Maryland.
Donald L. Rosenstein, MD
Professor and Director, Comprehensive Cancer Support Program
Bio: Donald Rosenstein, MD is Director of the UNC Comprehensive Cancer Support Program with joint appointments in the Departments of Psychiatry and Medicine. He also serves as Vice-Chair for the Division of Hospital Psychiatry and is the Training Director for the UNC Fellowship in Psychosomatic Medicine. He was previously Clinical Director of the National Institute of Mental Health (NIMH) and the Chief of the Psychiatry Consultation-Liaison Service. He also served as Vice-Chair of the NIH Medical Executive Committee and for many years chaired both the Clinical Center Ethics Committee and the NIMH Institutional Review Board. Dr. Rosenstein is currently President of the Academy of Psychosomatic Medicine. Dr. Rosenstein\'s research efforts have been focused on the interface of medicine and psychiatry. His clinical research protocols have addressed: neuropsychiatric toxicity associated with the systemic administration of cytokines; the role of magnesium metabolism in mood disorders; and the assessment and management of suicidality in the medical setting. He also has a longstanding interest in bioethics and professional integrity in medicine and clinical research. In 2008, Dr. Rosenstein was awarded the NIH Directors Award, the NIMH Directors Career Achievement Award for Significant Scientific Achievement and the Award in Appreciation of Service as Vice-Chair of the Medical Executive Committee and Extraordinary Service to the Ethical and Behavioral Health Needs at the NIH Clinical Center. Dr. Rosenstein did his undergraduate work at Wesleyan University and received his MD from Northwestern University School of Medicine. He completed his residency in Adult Psychiatry at Yale University